Literature DB >> 21251418

Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma.

Shun Li Shen1, Li Jian Liang, Bao Gang Peng, Qiang He, Ming Kuang, Jia Ming Lai.   

Abstract

BACKGROUND: Most patients with hepatocellular carcinoma (HCC) have advanced-stage disease at diagnosis. The prognosis for patients with HCC is very poor, especially for those with portal vein tumour thrombi (PVTT). The purpose of our study was to observe the prognostic value of PVTT and tumour-infiltrating regulatory T cells (Tregs) and the correlation between them.
METHODS: We examined 76 HCC specimens by immunohistochemistry for CD4+, CD8+ T cells and Foxp3+ Tregs. The survival of patients was prospectively followed up. Patients with HCC were grouped according to the formation of PVTT or Treg infiltration status. We performed a Kaplan-Meier survival analysis to observe the difference in prognosis between the groups. We analyzed the correlation of Treg expression with clinical and pathologic features.
RESULTS: Survival analysis revealed that both the disease-free survival rate and total survival rate after hepatic resection were significantly lower in patients in the PVTT group than those in the non-PVTT group (p=0.026 and p=0.022, respectively). Likewise, both the disease-free survival rate and the total survival rate were significantly lower in patients in the high Treg group than those in the low Treg group (p=0.012 and p=0.023, respectively). We found that intratumoural Tregs were associated with PVTT formation (p=0.001) and that patients with high Treg infiltration had a higher percentage of PVTT formation.
CONCLUSION: Patients with PVTT formation or high intratumoural Treg infiltration tended to have a poor prognosis. Intratumoural Treg was associated with formation of PVTT in patients with HCC.
© 2011 Canadian Medical Association

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251418      PMCID: PMC3116706          DOI: 10.1503/cjs.028009

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  16 in total

Review 1.  Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.

Authors:  Masami Minagawa; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Authors:  Junliang Fu; Dongping Xu; Zhenwen Liu; Ming Shi; Ping Zhao; Baoyun Fu; Zheng Zhang; Huiyin Yang; Hui Zhang; Chunbao Zhou; Jinxia Yao; Lei Jin; Huifen Wang; Yongping Yang; Yang-Xing Fu; Fu-Sheng Wang
Journal:  Gastroenterology       Date:  2007-04-14       Impact factor: 22.682

3.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.

Authors:  Sytse J Piersma; Ekaterina S Jordanova; Mariëtte I E van Poelgeest; Kitty M C Kwappenberg; Jeanette M van der Hulst; Jan W Drijfhout; Cornelis J M Melief; Gemma G Kenter; Gert Jan Fleuren; Rienk Offringa; Sjoerd H van der Burg
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

4.  Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.

Authors:  François Ghiringhelli; Cedric Menard; Pierre Emmanuel Puig; Sylvain Ladoire; Stephan Roux; François Martin; Eric Solary; Axel Le Cesne; Laurence Zitvogel; Bruno Chauffert
Journal:  Cancer Immunol Immunother       Date:  2006-09-08       Impact factor: 6.968

5.  The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; Y Ji; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2001-09       Impact factor: 4.553

6.  Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.

Authors:  Q Li; B Xu; L Fu; X S Hao
Journal:  J Exp Clin Cancer Res       Date:  2006-09

7.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

Review 8.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

9.  [Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma].

Authors:  Wei-Xing Guo; Xiao-Bo Man; Hai-Xin Yuan; Jie Shi; Jie Xue; Meng-Chao Wu; Shu-Qun Cheng
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2007-08-14

10.  Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy.

Authors:  Li-Jian Liang; Wen-Jie Hu; Xiao-Yu Yin; Qi Zhou; Bao-Gang Peng; Dong-Ming Li; Ming-De Lu
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

View more
  9 in total

Review 1.  Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma.

Authors:  Ai-Bin Zhang; Yi-Gang Qian; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2016 Dec.       Impact factor: 3.066

2.  Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection.

Authors:  Nirupama Trehanpati; Shikha Shrivastav; Bhavana Shivakumar; Ritu Khosla; Suvercha Bhardwaj; Jaya Chaturvedi; Binayak Kumar; Sujoy Bose; Dinesh Mani Tripathi; Trinath Das; Puja Sakhuja; Archana Rastogi; Chagan Bhihari; Shivender Singh; Subhash Gupta; Shyam Kottilil; Shiv Kumar Sarin
Journal:  Clin Transl Gastroenterol       Date:  2012-10-04       Impact factor: 4.488

Review 3.  Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

4.  Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Lejia Sun; Gang Xu; Wenjun Liao; Huayu Yang; Haifeng Xu; Shunda Du; Haitao Zhao; Xin Lu; Xinting Sang; Yilei Mao
Journal:  Oncotarget       Date:  2017-06-13

5.  The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.

Authors:  Wei Yao; Jun-Chuang He; Yan Yang; Jian-Ming Wang; Ya-Wei Qian; Tao Yang; Lei Ji
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

Review 6.  Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis.

Authors:  Wei Ding; Xuezhong Xu; Yan Qian; Wenbo Xue; Yibo Wang; Jianguo Du; Lei Jin; Yulin Tan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis.

Authors:  Yong Huang; Huaiwei Liao; Yong Zhang; Rongfa Yuan; Fengmei Wang; Yingtang Gao; Peng Wang; Zhi Du
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 8.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09

Review 9.  Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma.

Authors:  Xiaoqin Zheng; Wenjie Jin; Shanshan Wang; Huiguo Ding
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.